Study to Assess the Efficacy of Rina-S Compared to Treatment of Investigator's Choice in Participants With Platinum Resistant Ovarian Cancer
Running, not enrolling · Phase 3
Conditions studied: Platinum-resistant Ovarian Cancer
In brief
This phase 3 study will be conducted in different countries all over the world. The purpose of this study is to compare how well Rina-S works against platinum-resistant ovarian cancer compared to chemotherapy drugs that are already approved and used for platinum-resistant ovarian cancer. Treatment in this study could be Rina-S or it could be 1 of 4 indicated chemotherapy agents that are considered standard medical care. There is an equal (50:50) chance of getting Rina-S or an approved chemotherapy agent as treatment in this study. No one will know what treatment they are assigned to until the first dose. All participants will receive active drug; no one will be given placebo.
Key facts
- Study ID
- NCT06619236
- Run by
- Genmab
- People needed
- 530
- Starts
- 2025-02-07
- Expected to finish
- 2028-05-23
- Last updated by the study team
- 2026-07-07
Who can join
Age: 18 and older. Sex: female. Healthy volunteers: not accepted.
Where it is running
- Arizona Center for Cancer Care (ACCC) - Biltmore — Scottsdale, Arizona, United States
- University of Arizona Cancer Center - Research and Administration at Main Campus — Tucson, Arizona, United States
- Providence Saint Joseph Medical Center - Roy and Patricia Disney Family Cancer Center — Burbank, California, United States
- University of California San Diego Moores Cancer Center — La Jolla, California, United States
- USCF Mission Bay — San Francisco, California, United States
- Kaiser Permanente - Vallejo Medical Center — Vallejo, California, United States
- UCHealth Cancer Care - Anschutz Medical Campus - University of Colorado Cancer Center — Aurora, Colorado, United States
- Hartford Hospital — Hartford, Connecticut, United States
- Yale School of Medicine — New Haven, Connecticut, United States
- Norwalk Hospital — Norwalk, Connecticut, United States
- SCRI - Florida Cancer Specialists - South Region Research Office — Fort Myers, Florida, United States
- Mount Sinai Comprehensive Cancer Center — Miami Beach, Florida, United States
- Orlando Health Cancer Institute - Downtown Orlando — Orlando, Florida, United States
- Sarasota Memorial Hospital — Sarasota, Florida, United States
- SCRI - Florida Cancer Specialists - West Palm Beach — West Palm Beach, Florida, United States
- Winship Cancer Institute of Emory University — Atlanta, Georgia, United States
- Northside Hospital Atlanta — Atlanta, Georgia, United States
- Augusta University Georgia Cancer Center — Augusta, Georgia, United States
- Kapi'olani Medical Center for Women and Children — Honolulu, Hawaii, United States
- Northwest Cancer Center - Dyer — Dyer, Indiana, United States
- University of Kansas Cancer Center — Kansas City, Kansas, United States
- HCA Midwest Health — Overland Park, Kansas, United States
- St. Elizabeth Healthcare - Edgewood — Edgewood, Kentucky, United States
- Baptist Health Lexington — Lexington, Kentucky, United States
- Alaska Women's Cancer Care — Anchorage, Alaska, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.